PMID- 23711768 OWN - NLM STAT- MEDLINE DCOM- 20140203 LR - 20211021 IS - 1878-5891 (Electronic) IS - 0378-5955 (Print) IS - 0378-5955 (Linking) VI - 302 DP - 2013 Aug TI - 'Ecstasy' enhances noise-induced hearing loss. PG - 96-106 LID - S0378-5955(13)00137-8 [pii] LID - 10.1016/j.heares.2013.05.007 [doi] AB - 'Ecstasy' or 3,4-methylenedioxy-N-methamphetamine (MDMA) is an amphetamine abused for its euphoric, empathogenic, hallucinatory, and stimulant effects. It is also used to treat certain psychiatric disorders. Common settings for Ecstasy use are nightclubs and "rave" parties where participants consume MDMA and dance to loud music. One concern with the club setting is that exposure to loud sounds can cause permanent sensorineural hearing loss. Another concern is that consumption of MDMA may enhance such hearing loss. Whereas this latter possibility has not been investigated, this study tested the hypothesis that MDMA enhances noise-induced hearing loss (NIHL) by exposing rats to either MDMA, noise trauma, both MDMA and noise, or neither treatment. MDMA was given in a binge pattern of 5 mg/kg per intraperitoneal injections every 2 h for a total of four injections to animals in the two MDMA-treated groups (MDMA-only and Noise + MDMA). Saline injections were given to the animals in the two non-MDMA groups (Control and Noise-only). Following the final injection, noise trauma was induced by a 10 kHz tone at 120 dB SPL for 1 h to animals in the two noise trauma-treated groups (Noise-only and Noise + MDMA). Hearing loss was assessed by the auditory brainstem response (ABR) and cochlear histology. Results showed that MDMA enhanced NIHL compared to Noise-only and that MDMA alone caused no hearing loss. This implies that "clubbers" and "rave-goers" are exacerbating the amount of NIHL when they consume MDMA and listen to loud sounds. In contrast to earlier reports, the present study found that MDMA by itself caused no changes in the click-evoked ABR's wave latencies or amplitudes. CI - Copyright (c) 2013 Elsevier B.V. All rights reserved. FAU - Church, Michael W AU - Church MW AD - Department of Otolaryngology & Head Neck Surgery, Wayne State University School of Medicine, Detroit, MI 48201, USA. mchurch@med.wayne.edu FAU - Zhang, Jinsheng S AU - Zhang JS FAU - Langford, Megan M AU - Langford MM FAU - Perrine, Shane A AU - Perrine SA LA - eng GR - R25GM58905-10/GM/NIGMS NIH HHS/United States GR - R25 GM058905/GM/NIGMS NIH HHS/United States GR - P30 DC005188/DC/NIDCD NIH HHS/United States GR - 5P30DC005188-10/DC/NIDCD NIH HHS/United States GR - K01DA024760-05/DA/NIDA NIH HHS/United States GR - K01 DA024760/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20130525 PL - Netherlands TA - Hear Res JT - Hearing research JID - 7900445 RN - 0 (Adrenergic Uptake Inhibitors) RN - 9G34HU7RV0 (Edetic Acid) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) SB - IM MH - Adrenergic Uptake Inhibitors/adverse effects MH - Animals MH - Auditory Threshold/drug effects/physiology MH - Body Temperature MH - Cochlea/physiopathology MH - Edetic Acid/chemistry MH - Evoked Potentials, Auditory, Brain Stem/*drug effects MH - Hair Cells, Auditory, Inner/drug effects MH - Hair Cells, Auditory, Outer/drug effects MH - Hearing Loss, Noise-Induced/chemically induced/*pathology MH - Male MH - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects MH - Noise MH - Rats MH - Rats, Sprague-Dawley PMC - PMC3748725 MID - NIHMS485520 COIS- Disclosure Statement There are no conflicts of interest to report. EDAT- 2013/05/29 06:00 MHDA- 2014/02/04 06:00 PMCR- 2014/08/01 CRDT- 2013/05/29 06:00 PHST- 2013/04/09 00:00 [received] PHST- 2013/05/07 00:00 [revised] PHST- 2013/05/15 00:00 [accepted] PHST- 2013/05/29 06:00 [entrez] PHST- 2013/05/29 06:00 [pubmed] PHST- 2014/02/04 06:00 [medline] PHST- 2014/08/01 00:00 [pmc-release] AID - S0378-5955(13)00137-8 [pii] AID - 10.1016/j.heares.2013.05.007 [doi] PST - ppublish SO - Hear Res. 2013 Aug;302:96-106. doi: 10.1016/j.heares.2013.05.007. Epub 2013 May 25.